Vanda’s Bid to Expand Hetlioz to Insomnia Hits FDA Roadblock

Vanda’s Bid to Expand Hetlioz Use to Insomnia Hits FDA Roadblock

The FDA issued a complete response letter, indicating that it cannot approve Vanda’s supplemental New Drug Application for Hetlioz for insomnia in its present form.